Percutaneous coronary intervention plus medical therapy versus medical therapy alone in chronic coronary syndrome: a propensity score-matched analysis from the Swedish Coronary Angiography and Angioplasty Registry

被引:1
|
作者
von Koch, Sacharias [1 ]
Koul, Sasha [1 ]
Grimfjard, Per [2 ]
Andersson, Jonas [3 ]
Jernberg, Tomas [4 ]
Omerovic, Elmir [5 ]
Frobert, Ole [6 ,7 ]
Erlinge, David [1 ]
A Mohammad, Moman [1 ]
机构
[1] Lund Univ, Skane Univ Hosp, Dept Cardiol, Clin Sci, Lund, Sweden
[2] Vasteras Hosp, Dept Internal Med, Vasteras, Sweden
[3] Umea Univ Hosp, Dept Publ Hlth & Clin Med, Umea, Sweden
[4] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Stockholm, Sweden
[5] Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden
[6] Orebro Univ, Fac Hlth, Dept Cardiol, Orebro, Sweden
[7] Aarhus Univ Hlth, Dept Clin Med, Aarhus, Denmark
关键词
Percutaneous Coronary Intervention; Cardiovascular Diseases; Angina Pectoris; Atherosclerosis; Pharmacology; Clinical; COMPOSITE END-POINTS; MYOCARDIAL-INFARCTION; WIN RATIO; METAANALYSIS; SURVIVAL; SURGERY; TRIALS;
D O I
10.1136/heartjnl-2024-324307
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Percutaneous coronary intervention (PCI) is frequently used for patients with chronic coronary syndrome (CCS). However, the role of PCI beyond symptom relief in CCS remains controversial. The objective of this study was to determine whether PCI is associated with better outcomes, compared with medical therapy (MT) alone. Methods We conducted a retrospective cohort study. Using the Swedish Coronary Angiography and Angioplasty Registry, we included all patients with CCS undergoing coronary angiography in Sweden between 2010 and 2020. Two groups were formed based on treatment strategy: PCI+MT versus MT alone. One-to-one propensity score (PS) matching was used to address confounding. Outcome was assessed using matched win ratio analysis, a statistical method that ranks the components of the composite by clinical importance. The primary outcome was net adverse clinical event (NACE) within 5 years. In the win ratio analysis, the components of NACE were ranked as follows: (1) all-cause mortality, (2) myocardial infarction (MI), (3) bleeding and (4) urgent revascularisation. Secondary outcomes were the individual components of NACE, major adverse cardiovascular events (MACE) and cardiovascular mortality. Results After PS matching, two groups of 7220 patients each were formed. The hierarchical outcome analysis of NACE and MACE showed that PCI was associated with improved outcome (matched win ratio: 1.28 (95% CI 1.20 to 1.36, p<0.001) and matched win ratio: 1.38 (95% CI 1.29 to 1.48, p<0.001), respectively). The use of PCI was associated with higher win ratio of MI (matched win ratio: 1.15, 95% CI 1.04 to 1.28, p=0.008), urgent revascularisation (matched win ratio: 1.85, 95% CI 1.69 to 2.03, p<0.001) and cardiovascular mortality (matched win ratio: 1.15, 95% CI 1.00 to 1.34, p=0.044). No difference in win ratio was observed for all-cause mortality or bleeding. Conclusions In this study, which sought to evaluate the outcomes of patients with CCS using a hierarchical approach, patients selected for revascularisation with PCI experienced better outcome compared with MT alone.
引用
收藏
页码:1307 / 1315
页数:9
相关论文
共 50 条
  • [21] PERCUTANEOUS CORONARY INTERVENTION VERSUS MEDICAL THERAPY IN STABLE CORONARY ARTERY DISEASE: A META-ANALYSIS
    Patel, Pawan
    Singh, Mukesh
    Patel, Dipal
    Molnar, Janos
    Arora, Rohit R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [22] Propensity Score-Matched Analysis of Operator Radiation Exposure in Percutaneous Coronary Intervention with Radial versus Femoral Approach
    Caixeta, Adriano
    Leoncio, Ana
    Almeida, Breno
    Brito, Fabio, Jr.
    Mariani, Jose, Jr.
    Campos, Carlos
    Souza, Marco Tulio
    Gomes, Paula
    Pedrini, Stella
    Lemos, Pedro A.
    Gomes, Ivanise
    Franken, Marcelo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (18) : B130 - B131
  • [23] Influence of visual–functional mismatch on coronary flow profiles after percutaneous coronary intervention: a propensity score-matched analysis
    Masahiro Hoshino
    Taishi Yonetsu
    Tadashi Murai
    Yoshihisa Kanaji
    Eisuke Usui
    Masahiro Hada
    Rikuta Hamaya
    Yoshinori Kanno
    Tetsumin Lee
    Tsunekazu Kakuta
    Heart and Vessels, 2018, 33 : 1129 - 1138
  • [24] Outcome of percutaneous coronary intervention with the Absorb bioresorbable scaffold: data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
    Grimfjard, Per
    James, Stefan
    Persson, Jonas
    Angeras, Oskar
    Koul, Sasha
    Omerovic, Elmir
    Varenhorst, Christoph
    Lagerqvist, Bo
    Erlinge, David
    EUROINTERVENTION, 2017, 13 (11) : 1304 - 1311
  • [25] Eptifibatide Is Noninferior to Abciximab in Primary Percutaneous Coronary Intervention Results From the SCAAR (Swedish Coronary Angiography and Angioplasty Registry)
    Akerblom, Axel
    James, Stefan K.
    Koutouzis, Michail
    Lagerqvist, Bo
    Stenestrand, Ulf
    Svennblad, Bodil
    Oldgren, Jonas
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (06) : 470 - 475
  • [26] Comparison of successful percutaneous coronary intervention versus optimal medical therapy in patients with coronary chronic total occlusion
    Choo, Eun Ho
    Koh, Yoon-Seok
    Seo, Suk Min
    Lee, Jong Min
    Kim, Hee Yeol
    Park, Hun-Jun
    Kim, Pum-Joon
    Chang, Kiyuk
    Jeon, Doo Soo
    Kim, Dong Bin
    Her, Sung-Ho
    Park, Chul Soo
    Yoo, Ki-Dong
    Chung, Wook Sung
    Seung, Ki-Bae
    JOURNAL OF CARDIOLOGY, 2019, 73 (1-2) : 156 - 162
  • [27] Comparison of prasugrel and clopidogrel-treated patients with acute coronary syndrome undergoing percutaneous coronary intervention: A propensity score-matched analysis of the Acute Myocardial Infarction in Switzerland (AMIS)-Plus Registry
    Kurz, David J.
    Radovanovic, Dragana
    Seifert, Burkhardt
    Bernheim, Alain M.
    Roffi, Marco
    Pedrazzini, Giovanni
    Windecker, Stephan
    Erne, Paul
    Eberli, Franz R.
    EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2016, 5 (01) : 13 - 22
  • [28] Percutaneous Coronary Intervention Versus Medical Therapy for Chronic Total Occlusion of Coronary Arteries: A Systematic Review and Meta-Analysis
    Ka Hou Christien Li
    Ka Hei Gabriel Wong
    Mengqi Gong
    Tong Liu
    Guangping Li
    Yunlong Xia
    Jeffery Ho
    Luis Nombela-Franco
    Abhishek C. Sawant
    Simon Eccleshall
    Gary Tse
    Vassilios S. Vassiliou
    Current Atherosclerosis Reports, 2019, 21
  • [29] Percutaneous Coronary Intervention Versus Medical Therapy for Chronic Total Occlusion of Coronary Arteries: A Systematic Review and Meta-Analysis
    Li, Ka Hou Christien
    Wong, Ka Hei Gabriel
    Gong, Mengqi
    Liu, Tong
    Li, Guangping
    Xia, Yunlong
    Ho, Jeffery
    Nombela-Franco, Luis
    Sawant, Abhishek C.
    Eccleshall, Simon
    Tse, Gary
    Vassiliou, Vassilios S.
    CURRENT ATHEROSCLEROSIS REPORTS, 2019, 21 (10)
  • [30] Medical therapy in patients undergoing percutaneous coronary intervention: Results from the ROSETTA registry
    Eisenberg, MJ
    Okrainec, K
    Lefkovits, J
    Goudreau, E
    Deligonul, U
    Mak, KH
    Duerr, R
    Tsang, J
    Huynh, T
    Sedlis, S
    Brown, DL
    Brieger, D
    Pilote, L
    CANADIAN JOURNAL OF CARDIOLOGY, 2003, 19 (09) : 1009 - 1015